ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$8.85

Daily low

$8.44

Price at open

$8.70

52 Week High

$24.17

52 Week Low

$5.85

Market cap

245.0M

Dividend yield

0.00%

Volume

124,249

Avg. volume

508,263

P/E ratio

-3.61

Arcturus Therapeutics Holdings News